Clinical Trial Update: Study of AERAS 422 in Healthy Adults [Phase 1]

View source ↗

Summary

The Phase 1 study of the TB vaccine candidate AERAS 422 in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• AERAS 422

Snippet

Sponsor: Aeras | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED